Literature DB >> 11064433

Mouse models of chronic lung infection with Pseudomonas aeruginosa: models for the study of cystic fibrosis.

P K Stotland1, D Radzioch, M M Stevenson.   

Abstract

The discovery of the CFTR gene in 1989 has lead to rapid progress in understanding the molecular basis of cystic fibrosis (CF) and the biological properties of the cystic fibrosis transmembrane conductance regulator (CFTR) protein. However, more than 10 years later, recurrent lung infections with Pseudomonas aeruginosa, which lead to chronic lung disease and eventual respiratory failure, remain the major cause of morbidity and mortality among CF patients. A distinguishing feature of lung disease in CF is an exaggerated and persistent inflammatory response, characterized by the accumulation of excessive numbers of neutrophils and dysregulated cytokine production. The events leading to the establishment of lung infection with P. aeruginosa, especially the inflammatory and immunological events, and the relation between the CF defect and infection, remain largely undefined. Progress in this area has been hampered by the lack of a suitable animal model. An exciting achievement in the past few years has been the development of a number of variants of CFTR-deficient mice which exhibit defective cAMP-mediated Cl(-) conductance and have a range of clinical phenotypes from mild to severe. In parallel, a model of chronic P. aeruginosa lung infection has been established in genetically and immunologically well-defined inbred mouse strains which differ in susceptibility to this infection in the lung. BALB/c mice are resistant, while DBA/2 mice are extremely susceptible, with high mortality within 3 days of infection. C57BL/6 and A/J mice are relatively susceptible and experience low mortality. Furthermore, the bacterial load correlates with the magnitude and quality of the inflammatory response in the infected lungs of BALB/c and C57BL/6 mice. Although results of infection studies in CFTR-deficient mice have been variable, C57BL/6-Cftr(m1UNC)/Cftr(m1UNC) knockout mice compared to littermate control mice are highly susceptible to chronic P. aeruginosa infection in the lung. The availability of CFTR knockout mice and non-CF inbred mice differing in susceptibility to chronic P. aeruginosa infection offers useful tools for progress in understanding the genesis of chronic P. aeruginosa infection and the ensuing inflammation in the CF lung, as well as the relation between the CF defect and infection. Information generated from these studies will provide the rationale for the development of novel immunomodulatory measures capable of ameliorating or modulating the chronic inflammation associated with CF lung disease. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11064433     DOI: 10.1002/1099-0496(200011)30:5<413::aid-ppul8>3.0.co;2-9

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  21 in total

1.  Mucus secretion by single tracheal submucosal glands from normal and cystic fibrosis transmembrane conductance regulator knockout mice.

Authors:  Juan P Ianowski; Jae Young Choi; Jeffrey J Wine; John W Hanrahan
Journal:  J Physiol       Date:  2007-01-04       Impact factor: 5.182

2.  N-acetylcysteine enhances cystic fibrosis sputum penetration and airway gene transfer by highly compacted DNA nanoparticles.

Authors:  Jung Soo Suk; Nicholas J Boylan; Kanika Trehan; Benjamin C Tang; Craig S Schneider; Jung-Ming G Lin; Michael P Boyle; Pamela L Zeitlin; Samuel K Lai; Mark J Cooper; Justin Hanes
Journal:  Mol Ther       Date:  2011-08-09       Impact factor: 11.454

3.  Modular microfluidic system as a model of cystic fibrosis airways.

Authors:  M Skolimowski; M Weiss Nielsen; F Abeille; P Skafte-Pedersen; D Sabourin; A Fercher; D Papkovsky; S Molin; R Taboryski; C Sternberg; M Dufva; O Geschke; J Emnéus
Journal:  Biomicrofluidics       Date:  2012-08-02       Impact factor: 2.800

4.  Monitoring infection and inflammation in murine models of cystic fibrosis with magnetic resonance imaging.

Authors:  Vipul R Sheth; R Christiaan van Heeckeren; Alma G Wilson; Anna M van Heeckeren; Mark D Pagel
Journal:  J Magn Reson Imaging       Date:  2008-08       Impact factor: 4.813

5.  Persistence of Burkholderia multivorans within the pulmonary macrophage in the murine lung.

Authors:  Karen K Chu; Kelly L MacDonald; Donald J Davidson; David P Speert
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

Review 6.  Mechanisms of phagocytosis and host clearance of Pseudomonas aeruginosa.

Authors:  Rustin R Lovewell; Yash R Patankar; Brent Berwin
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-01-24       Impact factor: 5.464

7.  Pseudomonas aeruginosa cystic fibrosis isolates from individual patients demonstrate a range of levels of lethality in two Drosophila melanogaster infection models.

Authors:  Erika I Lutter; Monica M P Faria; Harvey R Rabin; Douglas G Storey
Journal:  Infect Immun       Date:  2008-02-19       Impact factor: 3.441

8.  Antimicrobial and biophysical properties of surfactant supplemented with an antimicrobial peptide for treatment of bacterial pneumonia.

Authors:  Brandon J H Banaschewski; Edwin J A Veldhuizen; Eleonora Keating; Henk P Haagsman; Yi Y Zuo; Cory M Yamashita; Ruud A W Veldhuizen
Journal:  Antimicrob Agents Chemother       Date:  2015-03-09       Impact factor: 5.191

9.  Differential susceptibility of inbred mouse strains to Burkholderia thailandensis aerosol infection.

Authors:  Lisa A Morici; Julie Heang; Tim Tate; Peter J Didier; Chad J Roy
Journal:  Microb Pathog       Date:  2009-10-21       Impact factor: 3.738

10.  A fusion protein vaccine containing OprF epitope 8, OprI, and type A and B flagellins promotes enhanced clearance of nonmucoid Pseudomonas aeruginosa.

Authors:  Eric T Weimer; Haiping Lu; Nancy D Kock; Daniel J Wozniak; Steven B Mizel
Journal:  Infect Immun       Date:  2009-04-06       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.